IL111825A0 - Poly-Beta-1->-4-n-acetylglucosamine - Google Patents

Poly-Beta-1->-4-n-acetylglucosamine

Info

Publication number
IL111825A0
IL111825A0 IL11182594A IL11182594A IL111825A0 IL 111825 A0 IL111825 A0 IL 111825A0 IL 11182594 A IL11182594 A IL 11182594A IL 11182594 A IL11182594 A IL 11182594A IL 111825 A0 IL111825 A0 IL 111825A0
Authority
IL
Israel
Prior art keywords
glcnac
relates
beta
present
acetylglucosamine
Prior art date
Application number
IL11182594A
Other languages
English (en)
Original Assignee
Marinepolymer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinepolymer Tech Inc filed Critical Marinepolymer Tech Inc
Publication of IL111825A0 publication Critical patent/IL111825A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C12N1/125—Unicellular algae isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/89—Algae ; Processes using algae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
IL11182594A 1993-12-01 1994-11-30 Poly-Beta-1->-4-n-acetylglucosamine IL111825A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/160,569 US5622834A (en) 1993-12-01 1993-12-01 Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture

Publications (1)

Publication Number Publication Date
IL111825A0 true IL111825A0 (en) 1995-01-24

Family

ID=22577431

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11182594A IL111825A0 (en) 1993-12-01 1994-11-30 Poly-Beta-1->-4-n-acetylglucosamine

Country Status (15)

Country Link
US (2) US5622834A (fr)
EP (2) EP1452546A3 (fr)
JP (3) JP3993633B2 (fr)
CN (1) CN1142833B (fr)
AT (1) ATE263785T1 (fr)
AU (1) AU695850B2 (fr)
CA (1) CA2177823C (fr)
DE (1) DE69433692T2 (fr)
DK (1) DK0731812T3 (fr)
ES (1) ES2219659T3 (fr)
IL (1) IL111825A0 (fr)
NZ (1) NZ277662A (fr)
PT (1) PT731812E (fr)
TW (1) TW458987B (fr)
WO (1) WO1995015343A1 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
JP3690771B2 (ja) * 1997-10-13 2005-08-31 株式会社ノエビア 皮膚外用剤
CN1098354C (zh) * 1998-11-12 2003-01-08 武汉大学 双酶催化法合成1－β－D－呋喃核糖苷－1，2，4－三氮唑－3－甲酰胺
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
JP2001031592A (ja) * 1999-07-16 2001-02-06 Fujibio Co Ltd キチン・キトサンによるハロゲン含有医薬の副作用防止方法及びそのための配合剤
US7041657B2 (en) * 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
EP1247819A1 (fr) * 2001-04-04 2002-10-09 Dainichiseika Color & Chemicals Mfg. Co. Ltd. Chitines purifiées et leur procédé de production
PL196686B1 (pl) * 2002-02-07 2008-01-31 Abbott Lab De Costa Rica Ltd Sposób oczyszczania chitozanu z białek
NZ541489A (en) * 2002-12-31 2011-06-30 Marinepolymer Tech Inc Topically applied vasoconstrictor for treatment in cardic catheterization complications
US7285266B2 (en) * 2003-02-24 2007-10-23 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and uses thereof
CN1232257C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗和控制物理化学因素致非特异性炎症的药物中的应用
EP1635782A1 (fr) * 2003-05-24 2006-03-22 JUVENA (International) AG Milieux de culture de tissus utilises comme composants de cosmetiques
EP1673134A4 (fr) 2003-09-12 2007-03-21 Marinepolymer Tech Inc Preservation d'acces vasculaire chez des patients en hemodialyse
CA2586587C (fr) * 2004-11-25 2011-01-04 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Procede destine a la determination de la tropomyosine dans le chitosan
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
JPWO2007046517A1 (ja) * 2005-10-17 2009-04-23 ヤマハ発動機株式会社 βキチンの製造方法
NZ599605A (en) 2007-02-19 2013-11-29 Marinepolymer Tech Inc Hemostatic compositions and therapeutic regimens
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
JP2010531878A (ja) 2007-06-27 2010-09-30 マリン ポリマー テクノロジーズ，インコーポレーテッド ＩＬ‐１５とＩＬ‐１５Ｒαとの複合体及びその使用
US8486033B2 (en) 2007-07-18 2013-07-16 Marine Polymer Technologies, Inc. Application of polymeric materials to screens to facilitate hemostasis and wound healing
CA2688196C (fr) * 2007-07-18 2014-01-07 Marine Polymer Technologies, Inc. Application de materiaux polymeres a des tamis pour faciliter l'hemostase et la cicatrisation de plaie
WO2009132226A1 (fr) * 2008-04-24 2009-10-29 Medtronic, Inc. Gel de chitosane thiolé
JP5833919B2 (ja) 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド キトサンと酸化多糖とに基づく保護用ゲル
US9198997B2 (en) 2008-04-24 2015-12-01 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
JP5738753B2 (ja) * 2008-04-24 2015-06-24 メドトロニック，インコーポレイテッド 再水和可能な多糖粒子およびスポンジ
WO2009132228A1 (fr) * 2008-04-24 2009-10-29 Medtronic, Inc. Composition protectrice contenant du chitosane
US8668899B2 (en) 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
NZ602909A (en) 2010-04-15 2015-01-30 Marinepolymer Tech Inc Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
CA2832859C (fr) 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Traitement de maladies avec des nanofibres de poly-n-acetylglucosamine
CN106045588A (zh) 2011-09-14 2016-10-26 诺维信生物农业公司 组合使用脂壳寡糖和/或壳寡糖与解磷微生物促植物生长
EP3335556A1 (fr) 2011-09-23 2018-06-20 Novozymes Bioag A/S L'utlisation des chitooligosaccharides dans un procede de l'amelioration d'une croissance vegetale
EP2854950B1 (fr) * 2012-05-30 2016-12-14 Clariant International Ltd Utilisation de n-méthyl-n-acylglucamines comme stabilisateurs au froid dans des solutions tensioactives
WO2014160136A1 (fr) 2013-03-13 2014-10-02 University Of Maryland, Office Of Technology Commercialization Pâte polymère biocompatible fonctionnelle avancée utilisée comme agent hémostatique pour le traitement de tissu et de cellules endommagés
EP2968190B1 (fr) * 2013-03-14 2018-10-17 Marine Polymer Technologies, Inc. Traitement de maladie par des nanofibres de poly-n-acétylglucosamine
CN104056298B (zh) * 2013-03-18 2017-04-26 李锋 无规共聚物的伤口应用
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
EP3034612A1 (fr) 2014-12-16 2016-06-22 Greenaltech, S.L. Procédés de production de chitine et de chitosane
WO2021029443A1 (fr) * 2019-08-14 2021-02-18 RIM, Chol Hak Composition hémostatique locale

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038367A (en) * 1963-05-28 1966-08-10 Beecham Group Ltd Penicillin derivatives
US3989535A (en) * 1974-02-11 1976-11-02 American Cyanamid Company Solution of poly(N-acetyl-D-glucosamine)
US3988411A (en) * 1974-02-11 1976-10-26 American Cyanamid Company Spinning and shaping poly-(N-acetyl-D-glucosamine)
JPS55152705A (en) * 1979-05-18 1980-11-28 Mitsubishi Rayon Co Ltd Preparation of water-soluble alkali chitin
US4378017A (en) * 1980-03-21 1983-03-29 Kureha Kagaku Kogyo Kabushiki Kaisha Composite material of de-N-acetylated chitin and fibrous collagen
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4605623A (en) * 1982-11-08 1986-08-12 Malette William Graham Method of altering growth and development and suppressing contamination microorganisms in cell or tissue culture
DE3583263D1 (de) * 1984-08-03 1991-07-25 Unitika Ltd Geformte gegenstaende aus chitin.
JPH0611810B2 (ja) * 1984-08-23 1994-02-16 ユニチカ株式会社 多孔性キチン成形体及びその製造方法
US4895724A (en) * 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
JPS62288602A (ja) * 1986-06-06 1987-12-15 Agency Of Ind Science & Technol キトサン変性物粒子の製造方法
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5093319A (en) * 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
JPH0691819B2 (ja) * 1991-05-27 1994-11-16 工業技術院長 デアセチラーゼの製造方法
US5229123A (en) * 1991-10-09 1993-07-20 Hoffmann-La Roche Inc. Antifungal agents
US5219749A (en) * 1991-10-09 1993-06-15 Institute For Molecular Biology & Biotechnology/Forth Process for isolating and preparing purified chitin deacetylase
IL100096A (en) * 1991-11-20 1996-03-31 Univ Ramot Method for entrapment of active materials in chitosan
AU3065192A (en) * 1991-12-20 1993-07-28 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
US5260002A (en) * 1991-12-23 1993-11-09 Vanderbilt University Method and apparatus for producing uniform polymeric spheres

Also Published As

Publication number Publication date
DE69433692D1 (de) 2004-05-13
JPH09506126A (ja) 1997-06-17
US5622834A (en) 1997-04-22
ATE263785T1 (de) 2004-04-15
JP2009079223A (ja) 2009-04-16
CN1142833A (zh) 1997-02-12
JP3993633B2 (ja) 2007-10-17
EP0731812B1 (fr) 2004-04-07
PT731812E (pt) 2004-08-31
CA2177823C (fr) 2002-04-30
JP2004211101A (ja) 2004-07-29
NZ277662A (en) 1998-04-27
EP1452546A2 (fr) 2004-09-01
CN1142833B (zh) 2010-06-02
EP0731812A1 (fr) 1996-09-18
ES2219659T3 (es) 2004-12-01
WO1995015343A1 (fr) 1995-06-08
AU695850B2 (en) 1998-08-27
EP1452546A3 (fr) 2004-10-13
DE69433692T2 (de) 2005-03-10
US5623064A (en) 1997-04-22
TW458987B (en) 2001-10-11
EP0731812A4 (fr) 1997-06-18
CA2177823A1 (fr) 1995-06-08
AU1296995A (en) 1995-06-19
DK0731812T3 (da) 2004-08-02

Similar Documents

Publication Publication Date Title
IL111825A0 (en) Poly-Beta-1->-4-n-acetylglucosamine
BG103694A (en) Improved method for the preparation and purification of n-alkylated asparginic derivative
CA2109368A1 (fr) Procede de clivage non aleatoire de l'amidon et produits de conversion de l'amidon de faible equivalent-dextrose obtenus par ce procede
EP1308553A3 (fr) Produits fibreux fonctionnels et procédé pour leur préparation
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
NO965339L (no) Fraksjonerte, polydisperse blandinger
CA2248006A1 (fr) Segments de liaison actives et leurs procedes de fabrication et de purification
FR2697023B1 (fr) Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
DE69116305T2 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
PT94331A (pt) Processo de preparacao de uma citosina desaminase termicamente estavel
EP0192988A3 (en) Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
AU1067388A (en) 4-thiazolidinecarboxylic acid derivative, its preparation and pharmaceutical compositions containing it
AU2102397A (en) Purification method
CA2162193A1 (fr) Proteine de recepteur de lactoferrine
ES2105988A1 (es) Procedimiento para purificar 7-sustituido-amino-desacetoxi-cefalosporinas mediante el empleo de membranas de filtracion.
EP0301314A3 (en) A method for the purification of interferon
CA2060505A1 (fr) Methode pour la recuperation de proteines recombinantes
AU2478292A (en) Purification of factor xiii
AU5024490A (en) Method of recovering purified epi protein from a solution especially a fermentation solution
DE69606959D1 (de) Verfahren zur Herstellung von Plättchen-Faktor-4
BR9813522A (pt) Processos para separar e purificar apm e metil éster de n-[n-(3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina e para a produção do derivado de apm, apm ou derivado de apm, e, adoçante
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method
KR970062047A (ko) 오우레오바시디움속 미생물 gm21을 이용한 고순도 플루란의 제조방법
TH17361A (th) โปรตีนจากรีคอมบิแนนท์ มิวแทนท์ ของpasteurella multocida กรรมวิธีสำหรับเตรียมลำดับดีเอนเอที่มีประมวลรหัสของโปรตีนเรพลิคอนที่มีลำดับดีเอนเอและเซลล์ที่ทรานสฟอร์มด้วยเรพลิคอนดังกล่าวชนิดเดียวกัน
BR9608074A (pt) Processo para a produção e purificação de esteres cìclicos

Legal Events

Date Code Title Description
KB20 Patent renewed for 20 years
EXP Patent expired